Cargando…
Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
OBJECTIVES: Cancer cachexia (CCA) is an intractable and ineffective metabolic syndrome that attacks 50–80% of cancer patients. It reduces patient's life quality, affects the efficacy of treatment, and then increases their mortality; however, there are no established therapeutic strategies for C...
Autores principales: | Wang, Jing, Wang, Yanling, Tong, Mengting, Pan, Hongming, Li, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612387/ https://www.ncbi.nlm.nih.gov/pubmed/31341892 http://dx.doi.org/10.1155/2019/2864384 |
Ejemplares similares
-
New Prospect for Cancer Cachexia: Medical Cannabinoid
por: Wang, Jing, et al.
Publicado: (2019) -
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis
por: Simon, Lucile, et al.
Publicado: (2021) -
Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials
por: Tong, Mengting, et al.
Publicado: (2019) -
Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis
por: Tong, Mengting, et al.
Publicado: (2017) -
Research progress of the clinicopathologic features of lung adenosquamous carcinoma
por: Wang, Jing, et al.
Publicado: (2018)